|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：N900200 |
| 產(chǎn)品名稱：NS-2028 |
| 產(chǎn)品CAS：204326-43-2 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
N900200 |
| 名稱: |
NS-2028 |
| 別名: |
8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one; |
| CAS號(hào): |
204326-43-2 |
| 分子式: |
C?H?BrN?O? |
| 外觀: |
白色固體 |
| 熔點(diǎn): |
160-163°C |
| 分子量: |
269.05 |
| 儲(chǔ)存: |
冰箱 |
| 溶解度: |
Chloroform, DMSO, Methanol |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
NS-2028 potent soluble guanylyl cyclase (sGC) inhibitor (Ki = 8 nM). NS-2028 blocks sGC activity in murine cerebellum induced by S-nitroso-glutathione and NMDA. NS-2028 inhibits VEGF-induced cGMP accumulation; abolishes VEGF-induced migration in postcapillary venular endothelial cells (CVEC). |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
